Science Immunology, 2020
Natural killer cell immunotypes related to COVID-19 disease severity

Maucourant C., Filipovic I., Ponzetta A. et al.

Proceedings of the National Academy of Sciences, 2020
Multiomic blood correlates of genetic risk identify presymptomatic disease alterations

Wainberg M., Magis A., Earls J. et al.

Clinical Cancer Research, 2020
Integration of Antiangiogenic Therapy with Cisplatin and Gemcitabine Chemotherapy in Patients with Nasopharyngeal Carcinoma

Chong W., Lim C., Sinha A. et al.

Frontiers in Immunology, 2020
Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers

He H., Olesen C., Pavel A. et al.

Clinical Research in Cardiology, 2020
Multi-proteomic approach to predict specific cardiovascular events in patients with diabetes and myocardial infarction: findings from the EXAMINE trial

Ferreira J., Sharma A., Mehta C. et al.

European Heart Journal, 2020
Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation

Wallentin L., Lindbäck J., Eriksson N. et al.

Science, 2020
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans

Arunachalam P., Wimmers F., Mok C. et al.

GSC Biological and Pharmaceutical Sciences, 2020
Susceptibility of men to SARS-CoV-2 may be caused by sex differences in ACE2 expression

Cell Reports Medicine, 2020
Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19

Rodriguez L., Pekkarinen P., Lakshmikanth T. et al.

Translational Psychiatry, 2020
Molecular linkage between post-traumatic stress disorder and cognitive impairment: a targeted proteomics study of World Trade Center responders

Kuan P., Clouston S., Yang X. et al.

Scientific Reports, 2020
Using proximity extension proteomics assay to discover novel biomarkers associated with circulating leptin levels in patients with type 2 diabetes

Vavruch C., Nowak C., Feldreich T. et al.

Analytical Biochemistry, 2020
The status of proteomics as we enter the 2020s: Towards personalised/precision medicine

Nice E.

American Journal of Reproductive Immunology, 2020
First‐trimester trophoblasts obtained by chorionic villus sampling maintain tolerogenic and proteomic features in successful pregnancies despite a history of unexplained recurrent pregnancy loss

Bruno V., Lindau R., Jenmalm M. et al.

Inflammatory Bowel Diseases, 2020
Salivary and Serum Inflammatory Profiles Reflect Different Aspects of Inflammatory Bowel Disease Activity

Majster M., Lira-Junior R., Höög C. et al.

Fluids and Barriers of the CNS, 2020
Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS

Bergman J., Svenningsson A., Liv P. et al.

Neuroendocrinology, 2020
A Plasma Protein Biomarker Strategy for Detection of Small Intestinal Neuroendocrine Tumors

Kjellman M., Knigge U., Welin S. et al.

European Heart Journal, 2020
Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention

Hoogeveen R., Pereira J., Nurmohamed N. et al.

Kidney International, 2020
A profile of multiple circulating tumor necrosis factor receptors associated with early progressive kidney decline in Type 1 Diabetes is similar to profiles in autoimmune disorders

Ihara K., Skupien J., Krolewski B. et al.

Scientific Reports, 2020
Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases

Saxena S., Lokhande H., Gombolay G. et al.

PLOS ONE, 2020
Inflammation, non-endothelial dependent coronary microvascular function and diastolic function—Are they linked?

Suhrs H., Schroder J., Bové K. et al.